World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
41
Citations
7622
World Ranking
4910
National Ranking
411

Stephen Todryk publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Stephen Todryk sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 124 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Stephen Todryk D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen Todryk sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 41 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Stephen Todryk is affiliated with Northumbria University in the United Kingdom. Their research primarily spans the field of Medicine, with a specific focus on Immunology, Oncology, Molecular Biology, Rehabilitation, and Biomedical Engineering as subfields of study.

The main topics covered in their work include:

  • Exercise and Physiological Responses
  • Cancer survivorship and care
  • SARS-CoV-2 and COVID-19 Research
  • Cancer therapeutics and mechanisms
  • NF-κB Signaling Pathways
  • Vaccines and immunoinformatics approaches
  • Immunotherapy and Immune Responses

Stephen Todryk has contributed to multiple peer-reviewed publications, with frequent appearances in journals such as the International Journal of Cancer, Vaccines, Biochemical Pharmacology, Lab on a Chip, and Frontiers in Physiology. Their research collaborations include frequent co-authors such as Paul Lehmann, Samuel T. Orange, Kirsty M. Hicks, John Saxton, and Alastair Jordan.

Recent scientific papers include:

  • Acute aerobic exercise-conditioned serum reduces colon cancer cell proliferation in vitro through interleukin-6-induced regulation of DNA damage, 2022, International Journal of Cancer
  • Next generation organoid engineering to replace animals in cancer drug testing, 2023, Biochemical Pharmacology
  • Integrating microfluidics and biosensing on a single flexible acoustic device using hybrid modes, 2020, Lab on a Chip
  • Role of monocytes/macrophages in renin-angiotensin system-induced hypertension and end organ damage, 2023, Frontiers in Physiology
  • The Effect of Menstrual-Cycle Phase on Immune Responses to a 5-km Cycling Time Trial: An Exploratory Study, 2023, International Journal of Sports Physiology and Performance

The frequency of publications in the International Journal of Cancer and Vaccines highlights their sustained involvement in cancer research and immunological studies. Collaboration with peers such as Paul Lehmann and Samuel T. Orange indicates a networked approach involving multiple disciplines within biomedical sciences.

Best Publications

  • Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells.

    Andrew G. Jarnicki;Joanne Lysaght;Stephen Todryk;Kingston H. G. Mills

  • Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression

    Alan Melcher;Stephen Todryk;Nicola Hardwick;Martin Ford

  • The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells

    Christine Galustian;Brendan Meyer;Marie-Christine Labarthe;Keith Dredge

  • Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake.

    Stephen Todryk;Alan A. Melcher;Alan A. Melcher;Nicola Hardwick;Emmanouela Linardakis

  • Clinical Assessment of a Recombinant Simian Adenovirus ChAd63: A Potent New Vaccine Vector

    Geraldine A. O’Hara;Christopher J. A. Duncan;Katie J. Ewer;Katharine A. Collins

  • Selective Expansion and Partial Activation of Human NK Cells and NK Receptor-Positive T Cells by IL-2 and IL-15

    Jean Dunne;Sara Lynch;Cliona O’Farrelly;Stephen Todryk

  • Protective Antitumor Immunity Induced by a Costimulatory Thalidomide Analog in Conjunction with Whole Tumor Cell Vaccination Is Mediated by Increased Th1-Type Immunity

    Keith Dredge;J. Blake Marriott;Stephen M. Todryk;George W. Muller

  • Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells

    Patricia Byrne;Peter McGuirk;Stephen Todryk;Kingston H. G. Mills

  • A Phase 2b Randomised Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya

    Philip Bejon;Jedidah Mwacharo;Oscar Kai;Tabitha Mwangi;Tabitha Mwangi

  • Facets of heat shock protein 70 show immunotherapeutic potential

    Stephen M Todryk;Michael J Gough;A Graham Pockley

  • Immunotherapeutic potential of whole tumour cells.

    Stephen Ward;David Casey;Marie-Christine Labarthe;Michael Whelan

  • Durable Human Memory T Cells Quantifiable by Cultured Enzyme-Linked Immunospot Assays Are Induced by Heterologous Prime Boost Immunization and Correlate with Protection against Malaria

    Sheila M. Keating;Philip Bejon;Tamara Berthoud;Jenni M. Vuola

  • Apoptosis or necrosis for tumor immunotherapy: what's in a name?

    Alan Melcher;Michael Gough;Stephen Todryk;Richard Vile

  • Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy.

    Keith Dredge;Blake J. Marriott;Stephen M. Todryk;Angus G. Dalgleish

  • An Intelligent Decision Support System for Leukaemia Diagnosis using Microscopic Blood Images.

    Siew Chin Neoh;Worawut Srisukkham;Li Zhang;Stephen Todryk

  • Heat shock proteins refine the danger theory

    S. M. Todryk;A. A. Melcher;A. G. Dalgleish;R. G. Vile

  • Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.

    Fiona M. Thompson;David W. Porter;Shinji L. Okitsu;Nicole Westerfeld

  • A synthetic peptide adhesion epitope as a novel antimicrobial agent

    Charles G. Kelly;Justine S. Younson;Ban Y. Hikmat;Stephen M. Todryk

  • Intelligent leukaemia diagnosis with bare-bones PSO based feature optimization

    Worawut Srisukkham;Li Zhang;Siew Chin Neoh;Stephen Todryk

  • Correlation of Memory T Cell Responses against TRAP with Protection from Clinical Malaria, and CD4+ CD25high T Cells with Susceptibility in Kenyans

    Stephen M. Todryk;Stephen M. Todryk;Stephen M. Todryk;Philip Bejon;Philip Bejon;Tabitha Mwangi;Magdalena Plebanski

Frequent Co-Authors

Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
Angus G. Dalgleish
Angus G. Dalgleish St George's, University of London
Philip Bejon
Philip Bejon University of Oxford
Sarah C. Gilbert
Sarah C. Gilbert University of Oxford
Sheila M. Keating
Sheila M. Keating University of California, San Francisco
Richard G. Vile
Richard G. Vile Mayo Clinic
Susanna Dunachie
Susanna Dunachie University of Oxford
Kevin Marsh
Kevin Marsh University of Oxford
Alan Melcher
Alan Melcher Institute of Cancer Research
Britta C. Urban
Britta C. Urban Liverpool School of Tropical Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare careers, many of which align closely with nursing and specialized practitioner roles. For those seeking entry into the healthcare field through a nursing lens, exploring the easiest lpn programs to get into can be an excellent starting point. These programs offer accessible paths to becoming a Licensed Practical Nurse while gaining foundational medical knowledge relevant to immunology and patient care.

Advancing further, individuals interested in clinical practice may consider the easiest np program options. These programs often provide a streamlined curriculum for becoming a Nurse Practitioner and can be tailored to focus on immunology-related specialties.

For those passionate about mental health and immunological influences on psychiatric conditions, the best online psychiatric mental health nurse practitioner programs offer outstanding clinical placements and specialized training. These programs integrate mental health nursing with immunologic insights crucial in holistic patient treatment.

Finally, cost-conscious students can explore cheapest online pmhnp certificate programs. Affordable options make advanced credentials in psychiatric nursing more accessible, supporting career growth linked to immunological expertise.

Best Scientists Citing Stephen Todryk

Trending Scientists

Recently Published Articles